RS-127445
RS-127445 is a chemical compound that acts as a selective antagonist for the 5-HT2B receptor. It is primarily used in scientific research to study the role of the 5-HT2B receptor in various physiological and pathological processes.
Chemical Properties
RS-127445 has a molecular formula of C_19H_22N_2O_2 and a molecular weight of 310.39 g/mol. The compound is characterized by its high affinity and selectivity for the 5-HT2B receptor, making it a valuable tool in pharmacological studies.
Pharmacology
RS-127445 is known for its ability to selectively block the 5-HT2B receptor without significantly affecting other serotonin receptors such as 5-HT2A and 5-HT2C. This selectivity is crucial for research focused on the specific functions and implications of the 5-HT2B receptor.
Mechanism of Action
As a 5-HT2B receptor antagonist, RS-127445 binds to the receptor and inhibits its activation by endogenous ligands such as serotonin. This inhibition can help elucidate the role of the 5-HT2B receptor in various biological processes, including cardiovascular function, gastrointestinal motility, and central nervous system activities.
Research Applications
RS-127445 is widely used in preclinical studies to investigate the involvement of the 5-HT2B receptor in different diseases and conditions. Some of the key areas of research include:
- Cardiovascular disease: Studies have explored the role of the 5-HT2B receptor in heart failure, pulmonary hypertension, and other cardiovascular conditions.
- Gastrointestinal disorders: Research has examined the impact of 5-HT2B receptor antagonism on irritable bowel syndrome and other gastrointestinal motility disorders.
- Neurological disorders: The compound has been used to study the potential involvement of the 5-HT2B receptor in migraine, depression, and other neurological conditions.
Safety and Toxicity
The safety profile of RS-127445 has been evaluated in various preclinical studies. While it is generally considered safe for use in research, the compound's long-term effects and potential toxicity in humans have not been fully established.
Conclusion
RS-127445 is a potent and selective 5-HT2B receptor antagonist that serves as a valuable tool in scientific research. Its ability to selectively block the 5-HT2B receptor has provided insights into the receptor's role in various physiological and pathological processes, making it an important compound in the field of pharmacology.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD